Glioblastoma multiforme is considered one of the most aggressive cancers, with an estimated 5-year survival …
A FOCUS ON ALK-POSITIVE NON-SMALL CELL LUNG CANCER
By
admin
In partnership with Wedgewood Communications, XVIVO developed two videos for Takeda Oncology to discuss lung cancer mechanism of disease and treatments.
THORACIC OUTLET SYNDROME
By
admin
Dr. Parth Shah, the Director of Vascular and Endovascular Surgery at the Thoracic Outlet Center …
VOXELOTOR AN INVESTIGATIONAL DRUG FOR SICKLE CELL DISEASE
By
Jordan Maire
In collaboration with Global Blood Therapeutics, our folks here at XVIVO created this medical animation to illustrate the mechanism of action of a potential drug candidate for the treatment of sickle cell disease (SCD).
IDIOPATHIC PULMONARY FIBROSIS AND THE EFFECTS OF TREATMENT
By
admin
The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.
PALOVAROTENE MOA
By
admin
Fibrodysplasia ossificans progressiva, or FOP, is an extremely rare and debilitating disorder, in which bone …
Can't Get Enough of XVIVO?
We’ve got you covered! Check out our latest wallpapers for stunning visuals!
Glioblastoma multiforme is considered one of the most aggressive cancers, with an estimated 5-year survival …
